Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Our understanding of the genetics and treatment options for primary effusion lymphoma (PEL) is lacking. Here the authors performed in vitro CRISPR/Cas9 knock-out screens to identify 210 PEL-specific oncogenic genes and report strategies for therapeutic intervention.
Saved in:
Main Authors: | Mark Manzano, Ajinkya Patil, Alexander Waldrop, Sandeep S. Dave, Amir Behdad, Eva Gottwein |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/4753b6af0a0c4636a623f9ba180cea46 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
by: Mark Manzano, et al.
Published: (2020) -
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
by: Chong Wang, et al.
Published: (2020) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
by: Hamidreza Aboulkheyr Es, et al.
Published: (2021) -
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
by: Carolina Caro-Vegas, et al.
Published: (2019) -
Evolutionarily conserved herpesviral protein interaction networks.
by: Even Fossum, et al.
Published: (2009)